Why Is Ambrisentan (Letairis) So Hard to Find? [Explained for 2026]

If you have been prescribed ambrisentan (brand name Letairis) for pulmonary arterial hypertension (PAH) and found yourself on the phone with multiple pharmacies trying to track it down, you are not alone. This medication — while effective at treating a serious, life-threatening condition — comes with a set of access challenges that can leave patients frustrated and, worse, without their medication. This guide explains exactly why ambrisentan can be hard to fill and what you can do about it in 2026.

What Is Ambrisentan and Why Is It Prescribed?

Ambrisentan belongs to a class of drugs called endothelin receptor antagonists (ERAs). It works by blocking the ETA receptor, which reduces the tightening of blood vessels in the lungs and lowers pulmonary arterial pressure. The FDA approved ambrisentan (as Letairis) in 2007 for adults with WHO Group 1 PAH to improve exercise ability and delay disease progression. It is often prescribed in combination with tadalafil, a combination supported by the landmark AMBITION clinical trial.

PAH is a rare disease — affecting roughly 15 to 50 people per million in the United States. Because the patient population is relatively small and the drug has specific handling requirements, it does not behave like a common medication at the pharmacy. That rarity is one of several reasons why it can be difficult to fill.

Reason 1: Brand Letairis Is Only Available at Specialty Pharmacies

Brand-name Letairis, manufactured by Gilead Sciences, is only dispensed through a restricted network of certified specialty pharmacies. This means you cannot walk into your neighborhood CVS, Walgreens, or Walmart and pick up branded Letairis — even if your insurance covers it.

Why? Because ambrisentan carries a boxed warning for fetal harm (teratogenicity). It is contraindicated during pregnancy and requires enrollment in the Ambrisentan REMS (Risk Evaluation and Mitigation Strategy) program for females of reproductive potential. Only pharmacies that have gone through REMS certification can dispense the medication to eligible female patients. This adds a layer of complexity that limits where you can fill the prescription.

Reason 2: Generic Ambrisentan Is Available at More Pharmacies — But Not All

The FDA approved generic ambrisentan in 2019, and multiple manufacturers — including Apotex, Cipla, Mylan, Sun Pharma, Teva, and Zydus — now produce it. Generic ambrisentan is available at retail pharmacies like Walgreens, Kroger, and Walmart, in addition to specialty pharmacies. This is good news for access compared to the brand.

However, because PAH is rare, not every retail pharmacy stocks generic ambrisentan on the shelf. Some pharmacies may need to order it, which can take 1 to 3 business days. And because different stores buy from different wholesalers, one chain location may have it while another location of the same chain does not. Calling around is still necessary for many patients.

Reason 3: There Was an Active Shortage in 2024

In May 2024, the American Society of Health-System Pharmacists (ASHP) published a drug shortage bulletin for ambrisentan tablets, specifically related to Zydus Pharmaceuticals' supply. The shortage was updated in December 2024 as other manufacturers maintained availability. By early 2026, multiple generic manufacturers — Apotex, Cipla, Mylan, Sun Pharma, Teva, and Zydus — as well as Gilead's brand Letairis, all have product available.

Even without an active national shortage, patients may still encounter localized gaps if their usual pharmacy does not carry a specific manufacturer's product or strength. The drug shortage history has made pharmacies and patients understandably cautious.

Reason 4: Insurance Prior Authorization Delays

Ambrisentan — especially the brand Letairis — is a specialty-tier medication that often requires prior authorization (PA) from your insurance plan before the pharmacy can dispense it. PA reviews can take several days to weeks if clinical documentation is not submitted promptly. During this waiting period, patients have no medication.

Insurance plans may also require step therapy — meaning they want evidence you tried a less-expensive alternative first — or quantity limits that restrict how many tablets are dispensed at one time. All of these administrative hurdles make timely access harder, even when the medication itself is available.

Reason 5: The High Cost Creates Affordability Barriers

Brand Letairis carries a retail cash price of approximately $13,000 to $14,200 per month. Generic ambrisentan costs around $2,000 to $2,100 per month for 30 tablets without any savings program. These are among the highest drug costs of any oral medication in the United States, which means insurance barriers, denials, and affordability challenges are a real and frequent obstacle for patients.

Savings programs do exist — including the Letairis Co-Pay Coupon (as low as $5/month for commercially insured patients) and the LEAP Patient Assistance Program for those without coverage. But navigating these programs takes time and effort, adding further delay. See our full guide to saving money on ambrisentan in 2026 for a full breakdown of savings options.

What Can You Do If You Cannot Find Ambrisentan?

Here are the most effective steps patients take when they have trouble filling ambrisentan:

Ask your specialty pharmacy to check if another location or partner pharmacy has the medication in stock

Call independent retail pharmacies in your area — generic ambrisentan is available without a specialty pharmacy for some patients

Use medfinder to have a service call pharmacies near you and identify which ones can fill your prescription

Contact the LEAP support line at 1-866-664-5327 if you have brand Letairis and need help navigating access challenges

Talk to your PAH specialist about bridge supplies or samples if your regular supply is delayed

How medfinder Helps

Rather than calling pharmacies yourself, medfinder does it for you. You tell us your medication, dosage, and ZIP code, and medfinder contacts pharmacies in your area to find which ones can fill your prescription. Results are texted directly to you. If you are struggling to locate ambrisentan, visit medfinder.com to get started. For more tips, see our guide on how to find ambrisentan in stock near you.

The Bottom Line

Ambrisentan is hard to find for a combination of reasons: REMS restrictions on brand Letairis, limited retail stocking of a rare-disease medication, a recent shortage history, insurance prior authorization hurdles, and extremely high costs that create access barriers. The good news is that multiple generic manufacturers are now producing ambrisentan, and proactive steps — like using medfinder — can help you locate your medication faster so your treatment is not interrupted.